First-quarter revenues for the IBO Lab Equipment/Consumables Index grew 3.9%, 2.9% organically, to $3,970.74 million. Operating profit improved 4.0% to $707.69 million, and operating margin added 30 basis points to 18.2% of sales. Diploma was removed from the Index, and Merck Millipore was added. Biohit’s first-quarter sales grew 9.9%, 7.5% excluding currency, to €10.4 million […]
Santa Clara, CA 7/6/11—Affymetrix has announced that it expects second-quarter revenues of $64–$65 million. This would be a 10%–11% decrease from a year ago. Product revenue is expected to be $58–$59 million for a 9%–11% decline. Product revenue includes $55 million in consumables sales and $3.5 million in instrument sales. Service revenue is estimated to […]
Apprehensions over the strength of the US economy and the sovereign debt crisis in Greece sent equity markets tumbling in early June. For the first half of the month, ending June 15, the Dow Jones Industrial Average slumped 5.4%. However, equity prices regained some ground as investors focused on the new austerity measures in Greece […]
Company Announcements First-quarter Roche Applied Science revenue declined 12%, down 3% in local currencies, to CHF 198 million ($211 million) due to a large one-time order a year ago. Custom Biotech sales grew 13%, Genomic Analysis sales increased 1%, Other revenue fell 10% and qPCR & Nucleic Acid Purification sales fell 16%. Europe/Middle East/Africa and […]
The continuing resolution (CR) to fund the US federal government through the end of fiscal year (FY) 2011 is $38.5 billion below the FY10 level. President Obama signed HR 1473 into law April 15 (see IBO 4/15/11). It is regarded as a CR instead of an appropriations bill, and therefore was not supplemented with clarifying […]
First-quarter 2011 Life Science Index sales grew 6.9%, 5.7% on a currency-neutral basis, to $3,074.88 million. Revenue growth for several companies was lessened by the natural disaster in Japan and strong year-over-year comparisons as a result of stimulus spending in the US and Japan. Operating profit improved 9.6% to $667.16 million, and operating margin gained […]
US equity markets trended lower in May following disappointing economic data, including weaker-than-expected manufacturing and durable goods orders. Other economic threats, such as inflation, unemployment and the European sovereign debt crisis, further soured investor sentiment. For the month, the Dow Jones Industrial Average, S&P 500 and NASDAQ fell 1.9%, 1.4% and 1.3%, respectively. Despite some […]
In the first quarter of the new year, instrument and laboratory product companies faced some challenges, including the aftereffects of the Japanese disaster and, in some cases, tough year-over-year comparisons. Despite these difficulties, the eight businesses whose quarterly results are profiled on pages 9–11 recorded total sales growth of 16.9% in the calendar-year first quarter. […]
For the first time in a decade, the growth rate of science and engineering (S&E) research space at US academic institutions has reversed its decline. The amount of S&E research space grew 4.4% from fiscal year (FY) 2007 to FY 2009 to comprise 196.1 million net assignable square feet (NASF), according to the NSF’s latest […]
Company Announcements Merck Millipore’s 2010 sales grew 81.0% to €1,681 million ($2,211 million). Legacy Millipore products represented 38% of sales. Organic revenue grew 5.6%. Europe, North America, Latin America and Asia/Africa/Australasia accounted for 39%, 24%, 9% and 28% of revenue, respectively. Sales this year are forecast to grow 51%–56%. In March, Thermo Fisher Scientific agreed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
